Rigopoulos Angelos Cardiologist
Associate Director, Cardiology DepartmentEducation & Academic Qualifications
- 1991: MD Degree in the National and Kapodistrian University, School of Medicine, Athens, Greece.
- 2003: PhD-thesis entitled “ Subclinical skeletal myopathy in hypertrophic cardiomyopathy and its relation with clinical characteristics of the disease” – grade “excellent” – Department of Cardiology, School of Medicine, University of Athens, Greece.
- German Cardiac Society Qualified Heart Failure Specialist (Zusatzqualifikation Herzinsuffizienz Deutsche Gesellschaft für Kardiologie)
- Certified implanter for transcatheter valve interventions and LAA-occluder implantation
PhD/ Thesis
2003: PhD-thesis entitled “ Subclinical skeletal myopathy in hypertrophic cardiomyopathy and its relation with clinical characteristics of the disease” – grade “excellent” – Department of Cardiology, School of Medicine, University of Athens, Greece.
Board Member
Fellow of the European Society of Cardiology (FESC)
Hellenic Society of Cardiology
German Cardiac Society (Deutsche Gesellschaft für Kardiologie, DGK)
European Association of Percutaneous Cardiovascular Interventions (EAPCI)
ESC Heart Failure Association (HFA)
ESC Acute Cardiovascular Care Association (ACCA)
ESC WG on Myocardial and Pericardial Diseases – Nucleus Secretary 2014-2018
Hellenic Society of Lipidology and Atherosclerosis
Editorial Boards
ESC Heart Failure IF 3,902
BMC Cardiovascular Disorders IF 2,078
Cells (Topics Board) IF 4,366
Hearts
AD-HOC REVIEWER for peer-reviewed international journals
Journal of the American College of Cardiology
Circulation Cardiovascular Interventions
Circulation Cardiovascular Imaging
International Journal of Cardiology
Catheterization and Cardiovascular Interventions
European Journal of Heart Failure
Current Cardiology Reviews
BMC Cardiovascular Disorders
Heart Failure Reviews
Cardiology
Heart Lung and Circulation
Hellenic Journal of Cardiology
Herz
Southern Medical Journal
Interventional Cardiology
Biomarkers in Medicine
Case Reports in Cardiology
Arrhythmia and Electrophysiology Reviews
Professional Experience
2017–2020 Consultant Cardiologist (Oberarzt Kardiologie), Head of Cardiac Catheterization Laboratory, Innere Medizin III, Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Halle, Germany
2012–2017 Consultant Cardiologist (Oberarzt Kardiologie), Head of Cardiac Catheterization Laboratory, Medizinische Klinik I, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany
2004-2011 Consultant Cardiologist, 2nd Department of Cardiology, University of Athens Medical School, Attikon University Hospital
2002 Training Fellowship (Scholarship from Hellenic Cardiological Society and Hellenic Heart Foundation) in Leopoldina Krankenhaus, Schweinfurt, Germany (Main subject: Interventional treatment of hypertrophic obstructive cardiomyopathy)
1998-2004 Clinical & Research Fellow, Catheterization Laboratory Department of Cardiology, University of Athens Medical School, Hippocration Hospital Athens
1998-2004 Clinical & Research Fellow, Pheidippides Project, Division of Inherited Cardiovascular Diseases, Department of Cardiology, University of Athens Medical School, Hippocration Hospital
1999-2000 On-call cardiologist, Intensive care unit, Athens Medical Centre, Palaio Faliro Clinic
Clinical and Research Interest
Clinical Interest:
Cardiac catheterization – Coronary angiography
Complex coronary intervention (a.o. bifurcation-PCI, left main stenoses)
Intracoronary imaging with intravascular ultrasound (IVUS) and optical coherence tomography (OCT)
Impella-supported PCI, cardiogenic shock
Right heart catheterization
Alcohol septal ablation (ASA) in hypertrophic obstructive cardiomyopathy (HOCM)
Transcatheter valve interventions
LAA-occluder implantation
PFO-occluder implantation
Research Interest:
Interventional cardiology
Cardiomyopathies
Heart failure
Cell protection in ischaemia and hypertrophy
Awards
1999 Best Oral Abstract presentation in 20th Panhellenic Cardiology Congress, Herakleion Crete (1999).
Ν.Ι. Protonotarios, Α.Α. Tsatsopoulou, Α.Ν. Anastasakis, Α.G. Rigopoulos, Α.Μ. Theopistou, E.L. Sevdalis, Ε. Karvouni, C.Ι. Stefanadis, P.Κ. Toutouzas. The natural course and prognosis of arrhythmogenic right ventricular cardiomyopathy in Naxos disease.2007 Best Poster Abstract presentation «Hans-Jürgen-Bretschneider-Posterpreis» in 31. Herbsttagung der Deutschen Gesellschaft für Kardiologie (31st Autumn Congress of German Cardiac Society), Kologne, 2007. Β. Pfeiffer, A. Neugebauer, C. Blank, P. Ziemssen, A. Rigopoulos, H. Seggewiss. Therapiestratefizierung bei jungen Patienten mit hypertropher Kardiomyopathie (Stratification of therapy in young patients with hypertrophic cardiomyopathy)
2009 Best Poster Abstract presentation in 3rd Panhellenic Congress of Medical Biochemistry, Athens, 2009. Β. Salpeas, Ε. Faviou, Ε. Sakadakis, Α.S. Kalogeropoulos, Α.G. Rigopoulos, Α. Triantafyllis, Ι. Rizos, Ε. Patsouris, D. Kremastinos. Aging and nuclear Farnesoid-X-receptor in the SHR animal model: Control and reshaping of molecular pathways of metabolic substrates usage, inflammatory disorders and survival.
2009 Distinction in 3rd Panhellenic Congress of Medical Biochemistry, Athens, 2009. Ε. Faviou, Ε. Sakadakis, Α.S. Kalogeropoulos, Α.G. Rigopoulos, Α. Triantafyllis, Ε. Voltyrakis, S. Papathanasiou, Τ. Papanikolaou, Ι. Rizos, D.T. Kremastinos. Association of metalloproteinases and atrial fibrillation in hypertensive patients.
2019 First Prize in Cardiology, BMA Medical Book Awards 2019 for The ESC Textbook of Cardiovascular Medicine, 3rd Edition and ESC CardioMed
Books
Book Chapters
Hubert Seggewiss, Angelika Batzner, Angelos G. Rigopoulos
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
In: Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. Europa Edition 2019, (Update)Angelos G. Rigopoulos, Hubert Seggewiss
Pericardial masses and congenital abnormalities
In: The ESC Textbook of Cardiovascular Medicine, 3rd Edition, ISBN 978-0-19-878490-6Hubert Seggewiss, Angelos G. Rigopoulos
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Ιn: Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. Europa Edition 2015, (Update)Hubert Seggewiss, Angelos G. Rigopoulos
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
In: Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. Europa Edition 2012, pp. 461-476 & Update 2015Hubert Seggewiss, Barbara Pfeiffer, Angelos Rigopoulos
Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy: Feasibility, safety and long-term results
In European Conference on Myocardial and Pericardial Disease: The First 50 Years of Cardiomyopathies, Belgrade, Serbia, 2009, pp.71Angelos G. Rigopoulos
Classification of cardiomyopathies
Cardiology (Textbook), Ed. D.T. Kremastinos, Paschalidis Editions 2009, Athens, Vol. ΙΙ, pp. 1163-1166ISBN 978-960-399-764-1
Angelos G. Rigopoulos
Hypertrophic cardiomyopathy: Advances in genetic aetiology and treatment
Cardiology (Textbook), Ed. D.T. Kremastinos, Paschalidis Editions 2009, Athens, Vol. ΙΙ, pp. 1167-1192ISBN 978-960-399-764-1
Angelos G. Rigopoulos, Aias Antoniadis
Primary coronary angioplasty in acute myocardial infarction with ST segment elevation
Cardiology (Textbook), Ed. D.T. Kremastinos, Paschalidis Editions 2009, Athens, Vol. ΙΙ, pp. 1359-1382ISBN 978-960-399-764-1
Angelos G. Rigopoulos
The role of echocardiography in hypertrophic cardiomyopathy and septal myocardial ablation
Echocardiographic Issues in Cardiovascular Diseases, Ed. Ι. Ν. Vlasseros, Athens 2008Hubert Seggewiss, Angelos Rigopoulos, Lothar Faber, Peer Ziemssen
Alcohol septal ablation
In Barry Maron, Ed. Diagnosis and Management of Hypertrophic Cardiomyopathy. Blackwell Futura 2004, pp. 259-278ISBN 978-1-4051-1732-6
Recent Publications
Total number of publications in peer- reviewed journals: 85
Mizia-Stec K, Caforio ALP, Charron P, Gimeno JR, Elliott P, Kaski JP, Maggioni AP, Tavazzi L, Rigopoulos AG, Laroche C, Frigy A, Zachara E, Pena-Pena ML, Olusegun-Joseph A, Pinto Y, Sala S, Drago F, Blagova O, Reznik E, Tendera M.
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology.
ESC Heart Fail. 2020 Sep 17. doi: 10.1002/ehf2.12854. Epub ahead of print. PMID: 32940421.Stähli BE, Varbella F, Schwarz B, Nordbeck P, Felix SB, Lang IM, Toma A, Moccetti M, Valina C, Vercellino M, Rigopoulos AG, Rohla M, Schindler M, Wischnewsky M, Linke A, Schulze PC, Richardt G, Laugwitz KL, Weidinger F, Rottbauer W, Achenbach S, Huber K, Neumann FJ, Kastrati A, Ford I, Ruschitzka F, Maier W; MULTISTARS AMI Investigators.
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
Am Heart J. 2020 Oct;228:98-108. PMID: 32871329Noutsias M, Melnyk H, Ali M, Daehnert I, Empen K, Sedding D, Rigopoulos AG.
Dual device closure of a bilobar left atrial appendage with a plug (Watchman 2.5™ 30 mm) and a pacifier (Amulet™ 20 mm) device.
Hellenic J Cardiol. 2020 Apr 15:S1109-9666(20)30070-1. doi: 10.1016/j.hjc.2020.03.005. Epub ahead of print. PMID: 32304818.Rigopoulos AG, Klutt B, Matiakis M, Apostolou A, Mavrogeni S, Noutsias M. Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.
Viruses. 2019 Jun 18;11(6):566. doi: 10.3390/v11060566. PMID: 31216741; PMCID: PMC6631559.Rigopoulos AG, Ali M, Abate E, Torky AR, Matiakis M, Mammadov M, Melnyk H, Vogt A, de Vecchis R, Bigalke B, Wohlgemuth W, Mavrogeni S, Noutsias M.
Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Heart Fail Rev. 2019 Jul;24(4):521-533. doi: 10.1007/s10741-019-09776-3. PMID: 30790171.Rigopoulos AG, Panou F, Sakadakis E, Frogoudaki A, Papadopoulou K, Triantafyllidi H, Ali M, Iliodromitis E, Rizos I, Noutsias M.
Cardiopulmonary Exercise Test Parameters at Three Months After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy Are Associated With Late Clinical Outcome.
Heart Lung Circ. 2020 Feb;29(2):202-210. doi: 10.1016/j.hlc.2018.12.007. Epub 2019 Jan 22. PMID: 30773321.Rigopoulos AG, Ali M, Abate E, Matiakis M, Melnyk H, Mavrogeni S, Leftheriotis D, Bigalke B, Noutsias M.
Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy.
Heart Fail Rev. 2019 May;24(3):359-366. PMID: 30617667.Rigopoulos AG, Sakellaropoulos S, Ali M, Mavrogeni S, Manginas A, Pauschinger M, Noutsias M.
Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.
Heart Fail Rev. 2018 Nov;23(6):907-917. PMID: 29736811.Rigopoulos AG, Daci S, Pfeiffer B, Papadopoulou K, Neugebauer A, Seggewiss H. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Clin Res Cardiol. 2016 Nov;105(11):953-961. PMID: 27270758Rigopoulos AG, Seggewiss H. Hypertrophic cardiomyopathy.
Lancet. 2013 Apr 27;381(9876):1456. PMID: 23622277.